IDH1 p.R132C

Biomarker type: Somatic variant

Gene context: IDH1

HGVS.p: NP_005887.2:p.Arg132Cys

Precision oncology relationships for therapeutic response involving this biomarker.

Organizations	Biomarkers	Cancer types	Therapies
FDA (2)	IDH1 p.R132C	Acute Myeloid Leukemia	Ivosidenib
FDA (1) HC (1)	IDH1 p.R132C	Acute Myeloid Leukemia	Azacitidine, Ivosidenib
FDA (1)	IDH1 p.R132C	Myelodysplastic Syndromes	Ivosidenib
FDA (1) HC (1)	IDH1 p.R132C	Cholangiocarcinoma	Ivosidenib
FDA (1)	IDH1 p.R132C	Acute Myeloid Leukemia	Olutasidenib
FDA (1) HC (1)	IDH1 p.R132C	Astrocytoma	Vorasidenib
FDA (1) HC (1)	IDH1 p.R132C	Oligodendroglioma	Vorasidenib